|
|
||||||||
Laboratory of Membrane Biochemistry and Biophysics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland 20892, USA
(RECEIVED April 28, 2005; FINAL REVISION July 19, 2005; ACCEPTED July 19, 2005)
Human peripheral-type cannabinoid receptor (CB2) was expressed in Escherichia coli as a fusion with the maltose-binding protein, thioredoxin, and a deca-histidine tag. Functional activity and structural integrity of the receptor in bacterial protoplast membranes was confirmed by extensive binding studies with a variety of natural and synthetic cannabinoid ligands. E. coli membranes expressing CB2 also activated cognate G-proteins in an in vitro coupled assay. Detergent-solubilized receptor was purified to 80%90% homogeneity by affinity chromatography followed by ion-exchange chromatography. By high-resolution NMR on the receptor in DPC micelles, it was determined that purified CB2 forms 1:1 complexes with the ligands CP-55,940 and anandamide. The receptor was successfully reconstituted into phosphatidylcholine bilayers and the membranes were deposited into a porous substrate as tubular lipid bilayers for structural studies by NMR and scattering techniques.
Keywords: cannabinoid receptor; CB2; E. coli; NMR; GPCR; anodic aluminum oxide
Abbreviations: CHAPS, 3-[(cholamidopropyl)dimethylammonio]-1-propanesulfonate CHS, cholesteryl hemisuccinate Tris salt GPCR, G-protein-coupled receptor H10, deca-histidine tag DM, n-dodecyl-
-D-maltoside MBP, E. coli maltose-binding protein OG, n-octyl-
-D-glucopyranoside Tev, tobacco etch virus TrxA, E. coli thioredoxin SOPC, 1-stearoyl-2-oleoyl-sn-glycero-3-phosphocholine POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine DPC, dodecylphosphocholine MOPS, 3-(N-Morpholino)propanesulfonic acid
Article and publication are at http://www.proteinscience.org/cgi/doi/10.1110/ps.051550305.
Reprint requests to: Alexei Yeliseev or Klaus Gawrisch, Laboratory of Membrane Biochemistry and Biophysics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892, USA; e-mail: yeliseeva{at}mail.nih.gov or gawrisch{at}helix.nih.gov; fax: (301) 594-0035.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |